Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Genscript Biotech (1548 HK)
Watchlist
57
Analysis
Health Care
•
Hong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Genscript Biotech
•
09 Jun 2024 16:00
China Healthcare Weekly (Jun.9) - New Akeso-Summit Deal, Jacobio Is a Good Bet, Genscript's Trouble
The new Akeso-Summit deal may pave the way for MNC to acquire Summit.Jacobio is a good target for potential M&A/license deal.Genscript faces US...
Xinyao (Criss) Wang
Follow
499 Views
Share
bearish
•
InnoCare Pharma Ltd
•
21 Jul 2024 09:37
China Healthcare Weekly (July.21)-Rumor About Akeso, Takeover Bid for Legend Bio, InnoCare's Trouble
Revenue of Akeso's AK112 and AK104 in 2024 may fall short of expectations. Legend Bio got a takeover bid, which is "a test" for Genscript....
Xinyao (Criss) Wang
Follow
257 Views
Share
bullish
•
Intouch Holdings
•
21 Jul 2024 01:17
Weekly Deals Digest (21 Jul) - Intouch/Gulf, China TCM, Huafa, Samson, Zhihu, Asics, Kokusai, Timee
Last week, notable developments occurred in Event-Driven (China TCM, Huafa, Samson, Zhihu, Intouch/Gulf, Legend Biotech, Capitol/Integral) and ECM...
Arun George
Follow
340 Views
Share
bullish
•
CK Infrastructure Holdings
•
20 Jul 2024 09:54
The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (July 19)
Equity ETF flows in China benefited from National Team buying this week. CK Infrastructure, Genscript Bio and BOC Aviation saw positive news...
David Mudd
Follow
373 Views
Share
bullish
•
Genscript Biotech
•
30 Jul 2023 09:36
China Healthcare Weekly (Jul.28) - Starting Point of New Prosperity, MNCs Change Strategy, Genscript
AD+RNAi could be the start point of next round of biopharmaceutical prosperity. MNCs have begun to adjust their strategic business model in...
Xinyao (Criss) Wang
Follow
289 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x